skip to main content
Close Icon

This website uses cookies. By continuing to use this site, you agree to our use of cookies. To find out more visit our Cookie Policy page.

Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

4 Total results for product and free and sample content found

Datamonitor Healthcare

Tapping into the potential commercial success of cell and gene therapies

By Pharma Intelligence 16 Nov 2016

Financing and deal trends, and clinical expectations and reimbursement issues in the regenerative medicine

Topics Cell and gene therapy

Datamonitor Healthcare

Gene therapy

26 Oct 2016

Topics Cell and gene therapy

Datamonitor Healthcare

Celgene opts in on Juno’s early-phase CAR-T therapies for $1bn upfront

By Zachary McLellan 02 Jul 2015

On 29 June 2015, Celgene and Juno Therapeutics announced a global collaboration for the development and commercialization of chimeric antigen receptor T cells (CAR-T) and T-cell receptor

Topics Cell and gene therapy

Trialtrove

Recent Trends In Personalized Medicine

By Fern Barkalow 10 Mar 2014

To further encourage the use of biomarkers in clinical trials, the United States FDA issued additional biomarker guidance in August 2011 designed in part to help promote and harmonize biomarker development among regulatory agencies in the United States, European Union and Japan.

Topics Clinical trial optimization Cell and gene therapy

;

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888-670-8900
  • US Toll           : +1 908-547-2200
  • UK & Europe : +44 (20) 337 73737
  • Australia       : +61 2 8705 6907

Or email us your inquiry, so we can provide you the best possible customer service:
Pharma@informa.com

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: